Big Pharma's Response to Political Change

This chapter delves into the urgent dialogue among Big Pharma CEOs reacting to former President Trump's election victory and potential shifts in U.S. healthcare policies. It explores Robert F. Kennedy Jr.'s reform plans aimed at tackling corruption in health agencies and emphasizes the implications of food safety regulations on public health. The discussion raises concerns about the overall health of the population as a cornerstone for national strength, while critically assessing the motives behind health policies and the influence of media narratives.